Vanguard Asset Management’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10.9M Sell
299,031
-151,296
-34% -$5.49M 0.01% 679
2026
Q2
$15.9M Buy
450,327
+98,458
+28% +$2.91M 0.01% 590
2026
Q1
$9.7M Buy
+351,869
New +$9.04M 0.01% 673

Other funds holding ROIV

Vanguard Asset Management's ROIV Position: Q3 2026 in Review

Vanguard Asset Management reduced its Roivant Sciences (ROIV) stake by 34% in Q3 2026, selling an estimated $5.49M and leaving 299,031 shares worth $10.9M. The position accounts for 0.01% of the portfolio, ranked #679.

Vanguard Asset Management first reported a position in ROIV in Q1 2026 and has held it in 3 quarters since. The position peaked at $15.9M in Q2 2026. 462 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.

  • Vanguard Asset Management held 299,031 shares of Roivant Sciences worth $10.9M as of Q3 2026.
  • Vanguard Asset Management sold 151,296 Roivant Sciences shares in Q3 2026, an estimated $5.49M.
  • Roivant Sciences made up 0.01% of Vanguard Asset Management's portfolio in Q3 2026, its #679 holding.
  • Vanguard Asset Management first reported a position in Roivant Sciences in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Asset Management's Roivant Sciences position peaked at $15.9M in Q2 2026.
  • 462 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.

Based on Vanguard Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.